Enanta Pharma (ENTA) Tops Q1 EPS by 17c

Enanta Pharma (NASDAQ: ENTA) reported Q1 EPS of ($1.39), $0.17 better than the analyst estimate of ($1.56). Revenue for the quarter came in at $23.6 million versus the consensus estimate of $21.85 million.

For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• MIND Technology (MIND) Misses Q1 EPS by 5c
• Carvana (CVNA) PT Lowered to $85 at RBC Capital